Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine

被引:30
|
作者
Kaput, Jim
Perlina, Alla
Hatipoglu, Betul
Bartholomew, Amelia
Nikolsky, Yuri
机构
[1] Univ Illinois, Dept Surg, Chicago, IL 60612 USA
[2] European Nutrigenom Org, NuGO, Davis, CA 95616 USA
[3] Univ Calif Davis, NCMHD Ctr Excellence Nutr Genom, Davis, CA 95616 USA
[4] GeneGO, Encinitas, CA 92024 USA
[5] Univ Illinois, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60612 USA
关键词
15-dOH-prostaglandin J(2); dietary lipids; nutrigenomics; pharmacogenomics; rosiglitazone; Type; 2; diabetes;
D O I
10.2217/14622416.8.4.369
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The maintenance of health and the prevention and treatment of chronic diseases are influenced by naturally occurring chemicals in foods. in addition to supplying the substrates for producing energy, a large number of dietary chemicals are bioactive -that is, they alter the regulation of biological processes and, either directly or indirectly, the expression of genetic information. Nutrients and bioactives may produce different physiological phenotypes among individuals because of genetic variability and not only alter health, but also disease initiation, progression and severity. The study and application of gene-nutrient interactions is called nutritional genomics or nutrigenomics. Nutrigenomic concepts, research strategies and clinical implementation are similar to and overlap those of pharmacogenomics, and both are fundamental to the treatment of disease and maintenance of optimal health.
引用
收藏
页码:369 / 390
页数:22
相关论文
共 50 条
  • [1] Nutrigenomics and pharmacogenomics: a scientific wonderland
    Blum, K
    Chen, TJH
    Blum, SH
    Downs, BW
    Braverman, ER
    Mengucci, JF
    Meshkin, B
    SOCIAL SCIENCE INFORMATION SUR LES SCIENCES SOCIALES, 2006, 45 (01): : 35 - 52
  • [2] Pharmacogenomics and nutrigenomics: synergies and differences
    Ghosh, D.
    Skinner, M. A.
    Laing, W. A.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2007, 61 (05) : 567 - 574
  • [3] Pharmacogenomics and nutrigenomics: synergies and differences
    D Ghosh
    M A Skinner
    W A Laing
    European Journal of Clinical Nutrition, 2007, 61 : 567 - 574
  • [4] Pharmacogenomics for personalized medicine - Advances in gene quantitation and amplification advance clinical applications
    Kelly, EB
    GENETIC ENGINEERING NEWS, 2002, 22 (04): : 18 - +
  • [5] Clinical Pharmacogenomics: Applications in Nephrology
    Adams, Solomon M.
    Crisamore, Karryn R.
    Empey, Philip E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (10): : 1561 - 1571
  • [6] Pharmacogenomics and nutrigenomics of novel animal model for obesity
    Shimada, Yasuhito
    Nishimura, Yuhei
    Kuroyanagi, Junya
    Tanaka, Toshio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 21P - 21P
  • [7] CLINICAL PHARMACOGENOMICS AND CONCEPT OF PERSONALIZED MEDICINE
    Babic, Nikolina
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2012, 31 (04) : 281 - 286
  • [8] Pharmacogenomics and personalized medicine in clinical practice
    Manolopoulos, Vangelis G.
    Dechairo, Bryan
    Huriez, Alain
    Kuehn, Alexander
    LLerena, Adrian
    van Schaik, Ron H.
    Yeo, Kiang-Teck J.
    Ragia, Georgia
    Siest, Gerard
    PHARMACOGENOMICS, 2011, 12 (05) : 597 - 610
  • [9] Convolutional neural networks (CNNs): concepts and applications in pharmacogenomics
    Joel Markus Vaz
    S. Balaji
    Molecular Diversity, 2021, 25 : 1569 - 1584
  • [10] Pharmacogenomics, concepts for the future of perioperative medicine and pain management: A review
    Kaye, Alan D.
    Koress, Cody M.
    Novitch, Matthew B.
    Jung, Jai Won
    Urits, Ivan
    Viswanath, Omar
    Renschler, Jordan S.
    Alpaugh, Edward S.
    Cornett, Elyse M.
    BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2020, 34 (03) : 651 - 662